Question

A 45-year-old with BMI 33 and T2DM, A1c 8.5% on metformin, stage 3a CKD (eGFR 52), albuminuria 120 mg/g. Most appropriate next glucose-lowering agent with cardiorenal benefit?

Accepted Answer

Start an SGLT2 inhibitor

Answer

Start a sulfonylurea

Answer

Start pioglitazone

Answer

Start acarbose

Answer

Start prandial insulin

Practice question

A 45-year-old with BMI 33 and T2DM, A1c 8.5% on metformin, stage 3a CKD (eGFR 52), albuminuria 120 mg/g. Most appropriate next glucose-lowering agent with cardiorenal benefit?